KURA Earnings Date & History
Kura Oncology Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:38 PM ET
Kura Oncology Inc
Biotechnology
- Next earnings date
- Monday, November 2, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.91
- Revenue estimate
- $25.1M
KURA earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Wednesday, August 12, 2026 | Q2 2026 | $-0.90 | $-0.77 | +14.0% | $20.9M |
| Tuesday, May 12, 2026 | Q1 2026 | $-0.65 | $-0.83 | -28.6% | $18.3M |
| Thursday, March 5, 2026 | Q4 2025 | $-0.49 | $-0.92 | -86.0% | $17.3M |
| Tuesday, November 4, 2025 | Q3 2025 | $-0.87 | $-0.85 | +2.2% | $20.8M |
| Thursday, August 7, 2025 | Q2 2025 | $-0.47 | $-0.75 | -60.2% | $15.3M |
What the market is watching in KURA's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next KURA earnings date?
- Kura Oncology Inc is scheduled to report on Monday, November 2, 2026 (Time TBD). Dates can change until the company confirms them.
- Does KURA report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for KURA?
- Consensus EPS for the upcoming quarter is $-0.91, on revenue of $25.1M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
KURA earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.